Design
Review
Authors
Loading...
Modest LVEF gains in acute MI trials remain hypothesis-generating; leaves open progenitor cell efficacy in chronic ischemic HF pending rigorous RCTs.
Key points are not available for this paper at this time.
Dimmeler et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: